Rezolute (RZLT) Rent Expense (2012 - 2014)

Rezolute recorded quarterly Rent Expense of $88616.0 in Q3 2014, up 21.06% quarter-over-quarter from $73202.0 in Q2 2014, and up 588.98% year-over-year from $12862.0 in Q3 2013.

Rezolute's Rent Expense history runs 3 years deep, the most recent figure standing at $88616.0 for Q3 2014.

  • In Q3 2014, Rent Expense rose 588.98% year-over-year to $88616.0; the TTM figure through Sep 2014 stood at $210706.0 (up 199.62% YoY), while the FY2014 annual figure was $134952.0, up 84.22% from the prior year.
  • Rent Expense came in at $88616.0 for Q3 2014 at Rezolute, up from $73202.0 in the prior quarter.
  • In the past five years, Rent Expense ranged from a high of $88616.0 in Q3 2014 to a low of $10462.0 in Q1 2012.
  • A 3-year average of $30248.7 and a median of $22894.0 in 2013 frame the typical range for Rent Expense.
  • Across the five-year window, Rent Expense declined 18.55% in 2013 and soared 588.98% in 2014, its largest moves.
  • Rezolute's Rent Expense stood at $18531.0 in 2012, then surged by 39.7% to $25887.0 in 2013, then jumped by 242.32% to $88616.0 in 2014.
  • According to Business Quant data, Rent Expense over the past three periods registered $88616.0, $73202.0, and $23001.0 for Q3 2014, Q2 2014, and Q1 2014 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Rental Exp. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 9,656.91
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Rezolute 374.41 Mn 374.41 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2014 88,616.00
Sep 30, 2014 88,616.00
Jun 30, 2014 73,202.00
Jun 30, 2014 73,202.00
Mar 31, 2014 23,001.00
Mar 31, 2014 23,001.00
Dec 31, 2013 25,887.00
Dec 31, 2013 25,887.00
Sep 30, 2013 12,862.00
Sep 30, 2013 12,862.00
Jun 30, 2013 22,894.00
Jun 30, 2013 22,894.00
Mar 31, 2013 16,038.00
Mar 31, 2013 16,038.00
Dec 31, 2012 18,531.00
Dec 31, 2012 18,531.00
Sep 30, 2012 15,792.00
Sep 30, 2012 15,792.00
Jun 30, 2012 25,451.00
Jun 30, 2012 25,451.00
Mar 31, 2012 10,462.00
Mar 31, 2012 10,462.00